Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older: Cambridge, Massachusetts Monday, November 11, 2024, 12:00 Hrs [IST] Moderna, Inc., a le ...

GSK sued Moderna over the shots in Delaware federal court Tuesday, claiming the mRNA specialist ignored GSK-owned patents related to lipid mRNA vaccine formulation technology. The lawsuits ...

According to court documents, the lawsuits focus on Moderna's use of lipid nanoparticle encapsulation of mRNA vaccines, a technology used to protect the mRNA molecules as they are delivered to ...

Leerink Partners analyst Mani Foroohar assigned a Sell rating on Moderna (MRNA – Research Report) on November 7 and set a price target of ...

GlaxoSmithKline is suing Moderna for allegedly ... the foundation" for Moderna's mRNA vaccines for COVID-19 and RSV, Reuters ...

Northwestern University has filed a patent infringement lawsuit against Moderna, Inc. MRNA ... s lipid nanoparticle (LNP) technology without permission to develop its COVID-19 vaccines.

GSK claims Moderna used its patented mRNA vaccine ... These scientists developed formulations combining lipids and mRNA molecules to create vaccines that trigger immune responses against viral ...

This time, we have GSK (GSK) "GSK" filing a lawsuit against Moderna (NASDAQ:MRNA) accusing them of patent infringement on their lipid nanoparticle ... their COVID-19 vaccine, Spikevax, as well ...

the mRNA vaccines from Pfizer and Moderna — aren’t effective. Pfizer’s and Moderna’s vaccines were the first to use mRNA ...

Moderna, Inc. (NASDAQ:MRNA) is a pharmaceutical and biotechnology company specializing in RNA therapeutics, particularly mRNA vaccines. The company gained widespread recognition for its COVID-19 ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

The vaccine uses the same lipid nanoparticles (LNPs) as the Moderna COVID-19 vaccine. Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, ...